GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

Date: November 15, 2016
Pages: 125
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G9753EE904AEN
Leaflet:

Download PDF Leaflet

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabolic and urological diseases, immuno-inflammation and cancer, among others. The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders. Its vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company operates research facilities in France, Germany, the UK, Belgium, Spain, the US, Canada, and China. Its operations span Asia and the Middle East, Australasia, North America, South and Central America, and Europe. GSK is headquartered in Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
Oct 06, 2016: CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration
Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
Sep 19, 2016: GSK sets out further steps to address emerging global health security challenges

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

GlaxoSmithKline Plc - Key Facts
GlaxoSmithKline Plc - Key Employees
GlaxoSmithKline Plc - Key Employee Biographies
GlaxoSmithKline Plc - Major Products and Services
GlaxoSmithKline Plc - Pharmaceutical Pipeline Products Data
GlaxoSmithKline Plc, Pipeline Products by Therapy Area
GlaxoSmithKline Plc, Pipeline Products by Development Phase
GlaxoSmithKline Plc - History
GlaxoSmithKline Plc - Company Statement
GlaxoSmithKline Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

GlaxoSmithKline Plc - Business Description
GlaxoSmithKline Plc - Corporate Strategy
GlaxoSmithKline Plc - SWOT Analysis
SWOT Analysis - Overview
GlaxoSmithKline Plc - Strengths
GlaxoSmithKline Plc - Weaknesses
GlaxoSmithKline Plc - Opportunities
GlaxoSmithKline Plc - Threats
GlaxoSmithKline Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
Oct 06, 2016: CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration
Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
Sep 19, 2016: GSK sets out further steps to address emerging global health security challenges
Sep 06, 2016: Early study shows RTS,S malaria vaccine efficacy may improve by changing dosing schedule
Aug 27, 2016: GSK’s continued commitment to innovative respiratory research demonstrated in European Respiratory Society congress data presentations
Jul 27, 2016: Vectura initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance
Jul 27, 2016: GSK announces significant new investment in UK manufacturing network
Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer 125

LIST OF TABLES

GlaxoSmithKline Plc, Key Facts
GlaxoSmithKline Plc, Key Employees
GlaxoSmithKline Plc, Key Employee Biographies
GlaxoSmithKline Plc, Major Products and Services
GlaxoSmithKline Plc, Number of Pipeline Products by Therapy Area
GlaxoSmithKline Plc, Number of Pipeline Products by Development Stage
GlaxoSmithKline Plc, Pipeline Products By Therapy Area and Development Phase
GlaxoSmithKline Plc, History
GlaxoSmithKline Plc, Other Locations
GlaxoSmithKline Plc, Subsidiaries
GlaxoSmithKline Plc, Joint Venture
GlaxoSmithKline Plc, Key Competitors
GlaxoSmithKline Plc, Ratios based on current share price
GlaxoSmithKline Plc, Annual Ratios
GlaxoSmithKline Plc, Interim Ratios
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 124

LIST OF FIGURES

GlaxoSmithKline Plc, Pipeline Products by Therapy Area
GlaxoSmithKline Plc, Pipeline Products by Development Phase
GlaxoSmithKline Plc, Performance Chart (2011 - 2015)
GlaxoSmithKline Plc, Ratio Charts
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: